PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

PAR. SP, page-561

  1. 638 Posts.
    lightbulb Created with Sketch. 262
    Bedger, there have been quite a few deals the past weeks, but unfortunately most seem to be in the specialty care field, that seems to still be the focus for the large pharma players.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.